Business · 07/12/1998

FDA Stays Compliance for Rectal Sodium Phosphates Drug Products Until December 7, 1998

The Food and Drug Administration (FDA) has granted a stay of compliance for the regulation of warning and direction statements for over-the-counter (OTC) rectal sodium phosphates drug products until December 7, 1998, in response to requests and a citizen petition.